For the quarter ended September 2024, Steris (STE) reported revenue of $1.33 billion, down 1% over the same period last year. EPS came in at $2.14, compared to $2.03 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $1.34 billion, representing a surprise of -0.58%. The company delivered an EPS surprise of +1.42%, with the consensus EPS estimate being $2.11.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they c ...

Steris (STE) came out with quarterly earnings of $2.14 per share, beating the Zacks Consensus Estimate of $2.11 per share. This compares to earnings of $2.03 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 1.42%. A quarter ago, it was expected that this medical products maker would post earnings of $2.01 per share when it actually produced earnings of $2.03, delivering a surprise of 1%.Over the last four quarters, the company ...

Exhibit 99.1 STERIS Announces Financial Results for Fiscal 2025 Second Quarter • Total revenue from continuing operations increased 7%; constant currency organic revenue grew 7% • As reported EPS from continuing operations increased to $1.51; adjusted EPS increased to $2.14 • Fiscal 2025 outlook reiterated DUBLIN, IRELAND - (November 6, 2024) - STERIS plc (NYSE: STE) ("STERIS" or the "Company") today announced financial results for its fiscal 2025 second quarter ended September 30, 2024. Total revenue from ...

Total revenue from continuing operations increased 7%; constant currency organic revenue grew 7%As reported diluted EPS from continuing operations increased to $1.51; adjusted EPS increased to $2.14Fiscal 2025 outlook reiterated DUBLIN, IRELAND, Nov. 06, 2024 (GLOBE NEWSWIRE) --  - STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2025 second quarter ended September 30, 2024. Total revenue from continuing operations for the second quarter of fiscal 2025 inc ...

Wall Street analysts expect Steris (STE) to post quarterly earnings of $2.11 per share in its upcoming report, which indicates a year-over-year increase of 3.9%. Revenues are expected to be $1.34 billion, down 0.4% from the year-ago quarter.Over the last 30 days, there has been a downward revision of 1.3% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.Ah ...

DUBLIN, IRELAND, Oct. 30, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.57 per share. The dividend is payable on December 19, 2024, to shareholders of record at the close of business on November 19, 2024.   Additional information about the U.S. tax treatment of dividends, including required Forms 8937, is available at www.steris-ir.com. STERIS is a leading global provider of products and service ...

DUBLIN, IRELAND, Oct. 23, 2024 (GLOBE NEWSWIRE) --  STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2025 second quarter financial results at 9:00 a.m. ET on November 7, 2024. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc.   A press release detailing financial results will ...

STERIS plc (STE) is expected to release second-quarter fiscal 2025 results shortly. In the last reported quarter, the company posted adjusted earnings per share (EPS) of $2.03, which beat the Zacks Consensus Estimate by 1%. STE beat on earnings in three of the trailing four quarters and missed the same once, delivering an average surprise of 0.58%. Find the latest EPS estimates and surprises on Zacks Earnings Calendar. STE's Q2 Estimates The Zacks Consensus Estimate for revenues is pegged at $1.34 billion, ...

A month has gone by since the last earnings report for Steris (STE) . Shares have added about 3% in that time frame, underperforming the S&P 500. Will the recent positive trend continue leading up to its next earnings release, or is Steris due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers. STERIS Q1 Earnings Beat Estimates, Operating Margin Falls STERI ...

STERIS plc (STE) rides on the robust performance of its Healthcare business.The company also benefits from the strong rebound prospects for its Applied Sterilization Technologies ("AST") segment. Meanwhile, headwinds such as foreign currency risks and macroeconomic challenges are concerning. Year to date, shares of this Zacks Rank #3 (Hold) company have risen 10.6% compared with the industry's 10% growth and the S&P 500's 18.4% increase. The renowned provider of infection prevention and other procedural pro ...